Lion Point Capital »

Minerva Neurosciences shares owned by Lion Point Capital

Quarter-by-quarter ownership of Minerva Neurosciences (NERV) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Minerva Neurosciences

Tip: Access up to 7 years of quarterly data

All positions including Minerva Neurosciences held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Minerva Neurosciences by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $141k 35k 4.02

More positions owned by Lion Point Capital

Milestone Pharmaceuticals (MIST)
Praxis Precision Medicines I Com New (PRAX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Fennec Pharmaceuticals (FENC)
Jasper Therapeutics Com New (JSPR)
Benitec Biopharma Com New (BNTC)
Royalty Pharma Shs Class A (RPRX)
Geron Corporation (GERN)
Syndax Pharmaceuticals (SNDX)
Ardelyx (ARDX)
Cue Biopharma (CUE)
Disc Medicine (IRON)
Sarepta Therapeutics (SRPT)
Biohaven (BHVN)
Humacyte (HUMA)

View all positions for Lion Point Capital

Top funds holding Minerva Neurosciences

Federated Investors
Vivo Capital
Logos Global Management
Farallon Capital Management
Ally Bridge Group
Longwood Capital Partners
Vanguard Group
Renaissance Technologies
BlackRock
Geode Capital Management
Apella Capital
Lion Point Capital
State Street Corporation
Acadian Asset Management
Rangeley Capital

View all funds holding Minerva Neurosciences